Literature DB >> 16076807

HRT and antidepressants.

Wendy L Wolfman.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16076807      PMCID： PMC1180635          DOI： 10.1503/cmaj.1050022

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Hormone replacement therapy and antidepressant prescription patterns: a reciprocal relationship.

Authors:  Roger S McIntyre; Jakub Z Konarski; Sophie Grigoriadis; Nancy C Fan; Deborah A Mancini; Kari A Fulton; Donna E Stewart; Sidney H Kennedy
Journal:  CMAJ       Date:  2005-01-04       Impact factor: 8.262

2.  Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.

Authors:  C L Loprinzi; J W Kugler; J A Sloan; J A Mailliard; B I LaVasseur; D L Barton; P J Novotny; S R Dakhil; K Rodger; T A Rummans; B J Christensen
Journal:  Lancet       Date:  2000-12-16       Impact factor: 79.321

3.  Phase III evaluation of fluoxetine for treatment of hot flashes.

Authors:  Charles L Loprinzi; Jeff A Sloan; Edith A Perez; Susan K Quella; Phillip J Stella; James A Mailliard; Michele Y Halyard; Sandhya Pruthi; Paul J Novotny; Teresa A Rummans
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

4.  Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.

Authors:  Michele L Evans; Elizabeth Pritts; Eric Vittinghoff; Karen McClish; Kevin S Morgan; Robert B Jaffe
Journal:  Obstet Gynecol       Date:  2005-01       Impact factor: 7.661

5.  Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.

Authors:  Vered Stearns; Katherine L Beebe; Malini Iyengar; Eric Dube
Journal:  JAMA       Date:  2003-06-04       Impact factor: 56.272

6.  Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2004 Jan-Feb       Impact factor: 2.953

7.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.